We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A Subset of Immune T-Cells Protects Against Metabolic Syndrome in Mouse Model

By LabMedica International staff writers
Posted on 16 Nov 2015
A subset of immune T-cells lacking the lytic protein perforin was found to be responsible for inducing the onset of metabolic syndrome (obesity, high blood pressure, high levels of blood sugar and cholesterol) in mice fed a normal diet.

Investigators at the Weizmann Institute of Science (Rehovot, Israel) were seeking molecular clues that would clarify the emerging evidence that immunological mechanisms underlie metabolic control of adipose tissue.

To this end they used bone marrow transplantation to generate a line of mice that lacked the perforin-containing granules (perf-DCs) normally found in this subset of dendritic T-cells. More...
Perforin is a protein that creates transmembrane tubules and is capable of lysing non-specifically a variety of target cells. This protein is one of the main cytolytic proteins of cytolytic granules, and it is known to be a key effector molecule for T-cell- and natural killer-cell-mediated cytolysis.

The investigators reported in the September 15, 2015, online edition of the journal Immunity that the perforin-deficient mice progressively gained weight and exhibited features of metabolic syndrome. This phenotype was associated with an altered repertoire of T-cells residing in adipose tissue and could be completely prevented by T-cell depletion in vivo.

A similar impact of perf-DCs on inflammatory T-cells was also found in a well-defined model of multiple sclerosis, experimental autoimmune encephlalomyelitis (EAE). Thus, perf-DCs probably represent a regulatory cell subpopulation critical for protection from metabolic syndrome and autoimmunity.

Related Links:

Weizmann Institute of Science



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.